Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03271372 |
Title | Adjuvant Avelumab in Merkel Cell Cancer (ADAM) |
Acronym | ADAM |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | University of Washington |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California Irvine Chao Family Comprehensive Cancer Center | Orange | California | 92868 | United States | Details | |
University of Colorado Cancer Center University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | United States | Details | |
Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
University of Michigan Comprehensive Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
University of North Carolina Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | United States | Details | |
Fred Hutch/University of Washington Cancer Consortium | Seattle | Washington | 98109 | United States | Details |